ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 122 filers reported holding ANAPTYSBIO INC in Q3 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,658,000 | -38.0% | 161,700 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $9,123,000 | -22.8% | 161,700 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $11,812,000 | +14.5% | 161,700 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $10,315,000 | -28.7% | 161,700 | +11.5% | 0.01% | -28.6% |
| Q3 2018 | $14,467,000 | – | 145,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |